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Aims Assessment of left ventricular (LV) volumes and ejection fraction (LVEF) with cardiac imaging is important in the
selection of patients for cardiac resynchronization therapy (CRT). Several observational studies have explored the
role of imaging-derived LV dyssynchrony parameters to predict the response to CRT, but have yielded inconsistent
results, precluding the inclusion of imaging-derived LV dyssynchrony parameters in current guidelines for selection
of patients for CRT.
...................................................................................................................................................................................................
Methods The EuroCRT is a large European multicentre prospective observational study led by the European Association of
Cardiovascular Imaging. We aim to explore if combing the value of cardiac magnetic resonance (CMR) and echo-
cardiography could be beneficial for selecting heart failure patients for CRT in terms of improvement in long-term
survival, clinical symptoms, LV function, and volumes. Speckle tracking echocardiography will be used to assess LV
dyssynchrony and wasted cardiac work whereas myocardial scar will be assessed with late gadolinium contrast
enhanced CMR. All data will be measured in core laboratories. The study will be conducted in European centres
with known expertise in both CRT and multimodality cardiac imaging.
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Introduction
The potential role of cardiac imaging to identify which patients with
heart failure benefit from cardiac resynchronization therapy (CRT)
has been assessed in several studies.1–6 Echocardiography is used to
assess left ventricular ejection fraction (LVEF) and volumes according
to current guidelines, but echocardiographic measures of cardiac dys-
synchrony were considered not sufficiently validated and robust to
be implemented in the current guidelines.7 Echocardiographic param-
eters have mostly been tested in single-centre studies with small co-
horts and often in retrospective studies.8–10 The prospective
observational PROSPECT trial showed that the initially proposed
echocardiographic parameters of cardiac dyssynchrony had a modest
accuracy to predict response to CRT.8 Subsequent studies have
shown that speckle tracking echocardiography may be a better tool
to reliably measure LV dyssynchrony.1,11–13 In the normal heart, all
LV segments contract in a relatively synchronized fashion and con-
tribute to blood ejection into the aorta. When there is electrical con-
duction delay, however, early and late activated segments contract at
different times and energy might be wasted in stretching opposing
segments.12,14–16 As observed typically in patients with left bundle
branch block, the early activated septum contracts prior to aortic
valve opening and stretches the LV lateral wall, and contraction in the
late activated lateral wall causes a variable degree of systolic lengthen-
ing of the septum.1,17,18 The negative work during systolic lengthening
makes no contribution to LV ejection, and therefore represents a
waste. It has been suggested that the amount of effective (positive)
work remaining in the dyssynchronous ventricle reflects the potential
for recovery of function after CRT.15,16,19 LV pressure–strain loops
are a novel and reliable tool for the non-invasive assessment of myo-
cardial work.15,16,20 Furthermore, the use of cardiovascular magnetic
resonance (CMR) in particular with late gadolinium enhancement
(LGE), permits the assessment of myocardial scar which has been
associated with poor response to CRT.21–23 The combination of LV
dyssynchrony assessment with speckle tracking echocardiography
and myocardial scar assessment with CMR has shown better accur-
acy to identify patients who will benefit from CRT.21,24,25 However,
these single-centre studies included only small cohorts of patients
and dyssynchrony was not extensively evaluated.
Therefore, we propose a European international observational
study (EuroCRT) to determine the role of multimodality imaging to
identify heart failure patients who will benefit from CRT. The object-
ives of the present study are as follows:
• to explore the combined value of LV mechanical dyssynchrony
and wasted cardiac work measured with speckle tracking echocar-
diography and of myocardial scar measured with LGE-CMR to ac-
curately identify patients who will benefit from CRT
• to test the robustness of this combined approach.
The results of this observational study will constitute a step for-
ward to proposing a new prospective randomized study.
Methods
The EuroCRT survey will be conducted in high-volume centres with spe-
cific expertise in the evaluation and treatment of heart failure patients
who are candidates for CRT and will be led by the ‘Research and
Innovation’ Committee of the European Association of Cardiovascular
Imaging (EACVI) with the help of the European Heart Rhythm
Association (EHRA). The selected centres will be involved in a 12-month
inclusion period followed by a 6-month follow-up period. Institutional
ethical approval will be requested in each centre according to the local
regulations complying with the principles outlined in the Declaration of
Helsinki for research in human subjects. Patients should be treated ac-
cording to the routine practice of each centre. The implantation of the
CRT should not be influenced by the data collected.
Study population
Inclusion criteria: patients who are listed on clinical grounds for CRT im-
plantation according to the current European Society of Cardiology
guidelines,6 and will consent to the study. They will be evaluated before
and 6 months after implantation. Patients undergoing upgrades of pace-
maker or implantable cardiac defibrillator will also be included.
Exclusion criteria: inappropriate echocardiographic image quality ac-
cording to the judgment of the investigator; absence of echocardiographic
follow-up at 6 months; absence of an indication for CRT according to the
current guidelines; general contraindication for CMR (including metallic
cerebral clips, non-MR conditional devices) and severe renal dysfunction
(glomerular filtration (eGFR) < 30 ml/min/1.73 m2). Patients in atrial fibril-
lation will also be excluded.
Protocol (Figure 1): The baseline evaluation includes clinical evaluation
[New York Heart Association (NYHA) functional class, 6-min walking
distance and quality of life], laboratory testing (with specific focus on NT-
pro brain natriuretic peptide determination), electrocardiographic (ECG)
recording, echocardiographic, and CMR evaluation of cardiac dimensions
and function. These investigations will be repeated at 6 months’ follow-
up. CMR will be repeated at 6 months in patients receiving a CMR-
conditional or compatible device.
Clinical information including cardiovascular risk factors, ECG and bio-
logical marker (creatinine, haemoglobin, sodium, NT-proBNP) will be
collected (Table 1). The ECG will be analysed and rhythm, PR interval
duration, QRS complexs of the Electrocardiogram (QRS) axis, duration,
and morphology will be recorded according to guidelines.26
Before implantation of the CRT device, patients will be imaged by
transthoracic echocardiography according to a predefined acquisition
protocol (Table 2)27,28 using the same ultrasound platform (ViVid E9, S70
Pre-implant 
Echocardiography
Secondary endpoint : reverse 
remodeling: LV EF and Volumes at 6-
month and opmally: recording of the 
whole TTE for the centralized analysis
CT of the coronary 
veins if available
Cardiac MR for LGE at 
least
CRT device implantaon 
according to usual pracces
Centralized analysis of the echo data: 
dyssynchrony, volumes, valvular disease, diastolic 
funcon, sPAP.
Packer composite primary
endpoint
Clinical evaluaon, NYHA-class, 
QoL, ECG, hearailure
hospitalizaon and adeath at 
6-month follow-up
CRF with the ECG descripon, the history of the HF : isch/non 
ischemic; blood pressure;  Age, BSA; BMI; risk factors; 
treatments; creanine, Natriurec pepdes, NYHA-class, QoL
Figure 1 Global presentation of the observational study.
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or E95, General Electric Healthcare, Horten, Norway). During echocardi-
ography, the ECG-trace recording will be carefully optimized to ensure
good visualization of the QRS onset throughout the echocardiographic
assessment. The frame rate of the images should be 50–90 Hz. The image
quality should be optimized to get the best visualization of the endocar-
dial and epicardial borders. At least three cardiac cycles will be acquired.
In addition to conventional grey scale images, contrast agents for cavity
opacification will be allowed when needed to obtain optimal determin-
ation of LV volumes and LVEF. Echocardiography will be interpreted on
site, the exam will be centralized using a web-platform (ASCENT: auto-
mated anonymization, and the same recording parameters with a specific
password for each co-investigator), and a centralized analysis (Inserm
1414 Clinical Investigation Center, Innovative Technology, Rennes,
F-35000) will be performed.
CMR will be performed before device implantation using standard
CMR scanners (1.5 and 3T) with cardiac software. In patients who
undergo implantation of an MR-conditional CRT device, CMR will be re-
peated at 6-month post-implantation. All CMR studies will be performed
according to a predefined CMR acquisition protocol detailed below, and
all anonymized data will be sent and analysed by the Bristol CMR Unit
core-lab. Images will be analysed by an expert operator ESC CMR level III
certified using a commercially available software (CMR42, Circle
Cardiovascular Imaging, Calgary, Canada).
CRT-procedure will be performed as per local standard operating
procedures. The post-implant period will be managed according to the
local procedures in each centre.
Study end points. At 12 month, the primary endpoint will be a reduc-
tion in left ventricular end-systolic volume of >_15% (i.e. LV reverse
remodelling).
The secondary endpoint will be the heart failure clinical composite re-
sponse.29,30 The composite endpoint was developed by Milton Packer29
at 12 month, This is a combined endpoint (QoL, NYHA-class, hospitaliza-
tion for heart failure and death) that has been extensively been used.31
Furthermore, event rates for death, hospitalisation for any cardiovas-
cular reason and the clinical improvement (as assessed with the NYHA
functional class, the 6 min walking test distance and the improvement in
quality of life according to questionnaires used in the Milton Packer
score)29 will be recorded.
Echocardiographic data analysis
A complete echocardiography including global longitudinal strain (GLS)
will be performed and recorded for a core laboratory analysis. Left atrial
(LA) volume, right ventricular (RV) size and function will be recorded ac-
cording to recommendation (including RV strain free wall).27,32
Assessment of dyssynchrony
Mechanical dyssynchrony will be quantified using a multi-parametric ap-
proach (Table 2).
.................................................................................................
Table 1 Clinical parameters to be recorded
Parameters Before
implantation
Six-month
follow-up
Age þ þ
Body mass index þ þ
Systolic blood pressure þ þ
Diastolic blood pressure þ þ
Heart rate þ þ
NYHA class þ þ
Six-minute walk test distance þ þ
Creatinine (micromole/l) þ þ
Haemoglobin (g/dl) þ þ
NT-proBNP (pg/ml) þ þ
ACEI/Sartan-dosage/day þ þ
Beta-blocker dosage/day þ þ
Diuretic dosage/day þ þ
MRA dosage/day þ þ
Ischaemicaetiology (Y/N) þ þ
Heart failure decompensation
(Y/N before implant and during
the 6-months of follow-up)
þ þ
NYHA, New York Heart Association; MRA, mineralocorticoide receptor
antagonists.
.................................................................................................
Table 2 Echocardiographic parameters or loops that
will be mandatory for the analysis or corelab analysis
Parameters/loops Before
implantation
Six-month
follow-up
Apical 4-, 2-, 3-ch.views showing
LV and LA (3 beats)
þ þ
Apical 4-, 2-, 3-ch.view with
colour Doppler on valves
þ þ
Dedicated loops on the
RV in 4-ch.view
þ þ
Mitral inflow (E, A, E-DT) þ þ
LVOT VTI (cm) þ þ
e’ (septal & lateral) (cm/s) þ þ
s’ (septal & lateral) (cm/s) þ þ
TR velocity (m/s) þ þ
RVs’ (cm/s) þ þ
LV EF (%) þ þ
GLS (%) þ þ
LVEDD (mm)(parasternal
long-axis view)
þ þ
LVESD (mm)(parasternal
long axis view)
þ þ
IVS and PW thickness (mm)
(parasternal long-axis view
þ þ
Parasternal long-axis view
loop (3 beats)
þ þ
Parsternal short-axis view at
the level of papillary muscle
þ þ
RV outflow tract VTI(cm) þ þ
Inferior vena cava loops (3 beats) þ þ
Optional: 4D volumetric acquisition
of the LV over 4 to 6 beats
þ þ
Apical 4-Ch. View colour DTI highest
frame rate loop (> 2 beats)
þ þ
LV, left ventricular; RV, right ventricular; LVEDD, Left ventricular end diastolic
diameter; LVESD, left ventricular end systolic diameter; IVS, inter ventricular sep-
tum thickness; PW, posterior wall thickness; LVOT, left ventricular outflow tract;
TR, tricuspid regurgitation.
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Intra-ventricular dyssynchrony will be defined by the presence of sep-
tal flash33 and/or apical rocking.34 These two parameters have been previ-
ously described and will be assessed qualitatively.34,35 Septal flash is a
premature and short contraction of the septum during the QRS and then
before the aortic valve opening. Apical rocking is a displacement or the
LV-apex towards the lateral wall.
Systolic mechanical dispersion will be quantified according to the
methodology previously proposed.36
In addition to these two approaches, Mitral inflow pattern, Mitral in-
flow duration will be measured.37 The pattern of LV-septum deformation
will be analysed according to Marechaux et al.38
Quantification of cardiac work
Cardiac work will be calculated as a function of time throughout the car-
diac cycle from the time-strain curve recordings and the estimated LV
pressure. Peak systolic LV pressure will be assumed to be equal to peak
arterial pressure measured with cuff manometer, as the average of three
recordings. Cardiac work will be assessed by calculating the rate of seg-
mental shortening (strain rate) by differentiation of the strain curve and
multiplying this with instantaneous LV-pressure. This product is a meas-
ure of instantaneous power, which will be integrated over time to give
work as a function of time in systole, defined as the time interval from mi-
tral valve closure to mitral valve opening. Two-dimensional imaging of
.................................................................................................
Table 3 Key imaging parameters that will be exam-
ined for their ability to predict the response to CRT
Parameters/loops Before
implantation
Six-month
follow-up
Localization: amount of LGE þ
LV volumes and diameters þ þ
Septal flash þ þ
Apical rocking þ þ
Pattern of LV longitudinal
strain.38
þ þ
Cardiac work indices þ þ
Strain delay indices (cardiac
work, dispersion)
þ þ
LA volumes and deformations þ þ
Right ventricular function
indices (TAPSE)
þ þ
LV mechanical dispersion þ þ
LV, left ventricular; LGE, late gadolinium enhancement.
Figure 2 Presentation of the impact of mechanical dyssynchrony on longitudinal strain curves: in blue: the septum with a too early contraction; in
red the lateral wall with a delayed contraction. GLS, global longitudinal strain; TTP, time to peak; WE, wasted energy.
Rational and design of EuroCRT 1123
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..mitral and aortic valves in parasternal long-axis view will be used to define
timing of opening and closure of the mitral and aortic valves.16,20,39,40
During the LV ejection period, work performed during segmental
elongation represents energy loss, defined as negative work (NegW).
Work performed during segmental shortening represented positive
work (PosW). During isovolumetric relaxation, this is reversed so
that work during shortening is considered negative work and work
during lengthening is considered positive work. Work efficiency (WE)
is defined as PosW/(PosWþNegW) 100. Global positive, negative,
and WE will be reported as the mean values of all LV segments
(Figure 2).
Cardiac magnetic resonance imaging
The CMR protocol includes standard long- axis views (3-, 2-, and 4-cham-
ber views) followed by a full stack of continuous short-axis cine encom-
passing the LV/RV from base to apex using a breath-hold steady-state
free precession cine technique. (Figure 3)
LGE-CMR imaging will be performed in the same short- and long-axis
cine orientation 10–15 min after administration of 0.1 to 0.2 mmol/kg of
gadolinium-chelate contrast agent. Images will be acquired using an inver-
sion recovery prepared breath-hold gradient-echo technique (IR-GRE)
following a Lock-Locker TI shout sequence for the identification of the
optimal starting TI value to null the signal in the normal myocardium. The
inversion time will be progressively optimized to null normal myocardium
(typical values, 250–350 ms). Each slice will be obtained during a breath
hold of 10–15 s depending on the patient’s heart rate.
The parameters measured will be LV and RV volumes and ejection
fraction. LV fibrosis will be measured using the full-width-half-maximum
method of the tissue characterization module, and expressed both in
grams and in % of the LV mass, as previously described.41 The location
and numbers of myocardial segments affected by LGE will be recorded;
the transmural extent of LGE will visually assessed per segment using a 0–
4 score (0 = no LGE, 1 = 0–25% LGE, 2 = 26–50% LGE, 3 = 51–75%
LGE, 4 = >_75% LGE) and quantify also.
Figure 3 Example of the quantification of the LGE.
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LV-GLS will be measured from two long-axis cine images using
feature-tracking analyses module.
Statistical analysis
The baseline demographic, clinical, echocardiographic, and CMR charac-
teristics will be compared between patients who have met the primary
end-point and those remaining free from end points at 12 month. Similar
comparison and description will be performed according to secondary
end points.
After the normality of the distribution is assessed using the
Kolmogorov–Smirnov test, all baseline continuous variables will be com-
pared between the two groups for statistically significant differences using
Student’s t-test or the Mann–Whitney test, as appropriate. Categorical
variables will be compared using the v2 test or Fisher’s exact test. The in-
dependent determinant of CRT response will be assessed using logistic
regression. Firstly, univariate analyses will be performed, and odds ratios
and 95% of confidence intervals (CI) will be reported. Secondly, all uni-
variate variables with a P-value <0.10 will be included in a backward step-
wise model. Special care will be maintained to avoid collinearity among
the included variables. In this regard, variables with a high degree of collin-
earity will be selected according to the best univariate P-value. Final vari-
ables identified as independently associated with the CRT-response will
be confronted to the previously established predictive score (i.e., the
Bernard et al. score42). According to the current literature and our ex-
perience, we anticipate including up to six variables (with low collinearity)
from the dyssynchrony analysis and CMR parameters in the logistic re-
gression model aiming to identify the independent determinants of non-
response.
From the literature, the expected response rate to CRT is 70%.
According to the main secondary endpoint (reduction in LVESV of at
least 15%), the rate response is 50% in the SEPTAL CRT trial, resulting
in 50–40% of patients potentially non-responders, according to the LV
reverse remodelling criteria.43 Consequently, using a ratio of 10
non-responders for each selected variable, a minimal number of 70
non-responders are needed to appropriately answer the primary object-
ive of the observational study. This results in a calculated total sample size
of 234 for an expected non-response rate of 30%. We aim to recruit 250
patients to account for missing data or loss of follow-up.
Discussion
Imaging modalities have been tested previously and have not met the
clinical expectations in improving the selection of candidates for
CRT.8,44,45 Nevertheless, new evidence on the role of imaging to se-
lect patients for CRT is encouraging.34,46–48 In particular, modern
multi-modality imaging approaches have the potential to improve the
selection of candidates for CRT (Table 4). From previous studies,21,25
it has been shown that the presence of myocardial scar is an import-
ant determinant of response to CRT. However, its integration in a
multi-parametric approach to select patients for CRT has not been
evaluated in large prospective multi-centre studies using dedicated
core labs for ultrasound and CMR studies.
By using echocardiography, new approaches for quantifying the
mechanical dyssynchrony have been proposed.33 There are also
issues that are not completely resolved like the relevance of right
ventricular function, of secondary mitral regurgitation or left atrial
size.49–51 Mechanical dispersion is also something that remains to be
explored in a large series of patients treated by CRT.36 Mechanical
dyssynchrony parameters can nowadays be quite automatically com-
puted and are taking advantage of the past studies and a better
....................................................................................................................................................................................................................
Table 4 Rational and design of EuroCRT: an international observational study on multimodality imaging and cardiac
resynchronization therapy
PROSPECT10 RethinQ26 Echo CRT27 Euro-CRTobjectives
Population 286 out of 498 enrolled 80 out of 172 enrolled 809 out of 1680 250
LVEF (%) 23.6 ± 7.0 26 ± 6 27.0 ± 5.4 <_35%
QRS duration (ms) 163 ± 22 106± 13 105 ± 12 >120
Follow-up (months) 6 6 19.4 6
LV end-diastolic Volume 230 ± 99 ml Volume 210 ± 75 ml Diameter 66.1 ± 7.4 mm Unknown
Use of time to peak indices in tissue
Doppler imaging
þ þ - -
Use of longitudinal strain - - - þ
Use of patterns of LV-regional function
and dyssynchrony
- - - þ
Use of indices of regional LV myocardial
function
- - - þ
Use of radial strain - - þ þ
Use of M-mode þ þ - þ
Use of pulse Doppler indices of dyssynchrony þ þ - þ
Use of any parameter of right ventricular
function or pressure
- - - þ
Use of CMR - - - þ
Result in term of interest of imaging indices - - - Unknown
LV, left ventricular; LVEF, left ventricular ejection fraction; CMR, cardiac magnetic resonance.
Rational and design of EuroCRT 1125
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understanding of the pathophysiology.52 The strain delay index has
been proposed and tested in the multi-centre MUSIC-trial involving
235 patients treated by CRT. The results were clearly encouraging.12
There are important results published with the cardiac work indices
obtained by computing longitudinal strain curves.53 In EuroCRT, we
will consider an approach combining the timing and the amount of
segmental deformation using the cardiac work indices previously
described.16,20 In addition, the septal flash and apical rocking are two
semi-quantitative approaches that are easy to apply and to test.33,54,55
These simple approaches have been tested and validated in some
studies but their relative value with respect to the quantitative assess-
ment of the cardiac wasted work has not been tested in any large
multicentre study. It has been decided to use only one sort of echo-
machine to increase to robustness. In addition, the centralized re-
viewing of the images will be extremely useful to assess the relative
reproducibility of the ‘automatically’ calculated parameters extracted
from strain curves against the variability of the septal flash and the ap-
ical rocking (i.e. comparing corelab vs, individual labs involved in
EuroCRT).34
Conclusion
EuroCRT will be the first large multi-centre European prospective
observational international study to test the role of CMR and mod-
ern echocardiographic-updated parameters to predict the response
to CRT among patients implanted according to the current
guidelines.
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